Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/16/23 16:37 | 11/16/23 | DMAC | Health | Drug | Pharmaceutical Preparations | Wambeke David J. | MN | O | Chief Bu | 3 | P.d | 949 | 1.80 | 0 | 527 | 527 | D | |||||||||||||||
6/27/23 16:11 | 6/23/23 | DMAC | Health | Drug | Pharmaceutical Preparations | Von Koch Thomas | V7 | T | 1 | P | 5,000 | 3.40 | 0 | 1,471 | 51 | 4,326 | I | |||||||||||||||
6/26/23 16:42 | 6/23/23 | DMAC | Health | Drug | Pharmaceutical Preparations | Giuffre Randall Michael | MN | D | 1 | P | 254 | 3.91 | 0 | 65 | 20 | 392 | D | |||||||||||||||
6/26/23 16:34 | 6/23/23 | DMAC | Health | Drug | Pharmaceutical Preparations | Pauls Dietrich John | MN | DO | P,CEO | 1 | P | 50 | 3.91 | 0 | 13 | 23 | 69 | D | ||||||||||||||
6/26/23 16:26 | 6/23/23 | DMAC | Health | Drug | Pharmaceutical Preparations | Semba Charles Pauling | MN | D | 1 | P | 50 | 3.91 | 0 | 13 | 75 | 30 | D | |||||||||||||||
6/26/23 16:21 | 6/23/23 | DMAC | Health | Drug | Pharmaceutical Preparations | Kellen Scott | MN | O | CFO,Secr | 1 | P | 39 | 3.91 | 0 | 10 | 45 | 32 | D | ||||||||||||||
6/26/23 16:03 | 6/23/23 | DMAC | Health | Drug | Pharmaceutical Preparations | Pilnik Richard D. | MN | D | 1 | P | 150 | 3.91 | 0 | 38 | 18 | 248 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |